about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityTriphasic blood pressure responses to cannabinoids: do we understand the mechanism?Endocannabinoid signalling: has it got rhythm?Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediatorRegulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses.Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisDifferential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619.Cannabinoid receptors in acute and chronic complications of atherosclerosis.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningDecreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injuryModulating the endocannabinoid system in human health and disease--successes and failuresModulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitationsCB1 cannabinoid receptor inhibition: promising approach for heart failure?Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptorsMechanisms of endothelial dysfunction in obesity-associated hypertension.Endocannabinoids and cardiac contractile function: pathophysiological implications.The therapeutic potential of novel cannabinoid receptorsThe emerging role of the endocannabinoid system in cardiovascular disease.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Cannabinoids and the Kidney: Effects in Health and Disease.Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury.Cardiovascular Complications of Marijuana and Related Substances: A Review.
P2860
Q24633122-C964BF48-539E-4B86-BDD1-4E762C5EC5EEQ24648835-00E7C3FA-5B36-468D-9C86-234032256C44Q27025612-1175EA0E-B15F-46B7-97EE-485EAAC4DD86Q34098217-4F8E4E73-92BD-4D2A-83AB-32F08E5C5E4BQ34116761-57C8C64B-13D9-4745-B1AC-06A44D2417DEQ34214049-CF4E1D54-FAF4-4D2E-AEC9-F2CD01CA3ADCQ34282113-1DDAE0CD-446B-47AB-AEE2-0841C2CC0947Q34545007-04036BFB-E5DB-4CA7-8FB7-31B3AE6891F3Q34655802-52B75121-ECD9-4BCE-A166-FA3D3E1C875BQ34973799-66566E14-4CED-48DC-B5BD-43ED341BB5D6Q36225837-7044531B-12B2-41E0-A74B-FF0A6F19D1A2Q36358717-F1E5722E-43A2-4C4B-B715-8F5769666D2CQ36416368-693EED4C-0B12-4D3B-86A5-DE7CD2EC03A5Q36416372-0F3C0B04-D393-4B3E-8A74-8869F896B484Q36426806-A8194E65-00F7-4B52-B997-AC56629AB171Q36431793-61270A61-B284-41D8-880C-9B4B938C7F61Q36933683-578C0873-878D-4869-9E28-85354DA9515EQ36940347-56EA65E2-DFE1-4318-A2F8-E302BF81BD24Q37160279-96B7F092-C5FE-446A-8F14-0EB2DE995707Q37285069-CF7453D3-60CF-4981-9604-7AB10EDCF0A8Q37371166-F0306829-58F9-4AB0-B68F-ECBC8579965EQ37401757-6F85E35D-3089-403B-8E51-09D3ED36BD96Q37402927-3C828A78-6DFE-4D04-86F8-DE37B294EB1EQ37439386-10F163C8-D8BF-463B-8432-ADCC6CA0BA2AQ38196398-13859F31-2391-48C4-B993-16950466F44DQ38651395-06B3EBA9-BDD5-4599-8F96-2A707DD0D832Q41150280-2A87946C-DCE5-4F3E-84EF-E6C5532DA7F3Q47316420-D203EEB2-4F35-4883-B7EE-5315B4A10E9A
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cardiovascular pharmacology of cannabinoids.
@ast
Cardiovascular pharmacology of cannabinoids.
@en
type
label
Cardiovascular pharmacology of cannabinoids.
@ast
Cardiovascular pharmacology of cannabinoids.
@en
prefLabel
Cardiovascular pharmacology of cannabinoids.
@ast
Cardiovascular pharmacology of cannabinoids.
@en
P2093
P2860
P1476
Cardiovascular pharmacology of cannabinoids.
@en
P2093
P2860
P304
P577
2005-01-01T00:00:00Z